Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Bioorganic & Medicinal Chemistry Letters Instructions to Contributors
Journal of Medicinal Chemistry | Ahead of Print
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier
Call for Papers: ACS Medicinal Chemistry Letters Special Issue on New Enabling Drug Discovery Technologies - Recent Progress | ACS Medicinal Chemistry Letters
Advanced Medicinal Chemistry Letters Referencing Guide · Advanced Medicinal Chemistry Letters citation (updated Mar 25 2023) · Citationsy
Advanced Medicinal Chemistry Letters
Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors. | Semantic Scholar
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 1, Pages 1-606 (1 January 2011) | ScienceDirect.com by Elsevier
ACS Medicinal Chemistry Letters | Ahead of Print
PDF) BMCL Bioorganic & Medicinal Chemistry Letters 20 (2010) 1156–1161
Bioorganic & Medicinal Chemistry Letters | Recent Advances in Medicinal Chemistry | ScienceDirect.com by Elsevier
ACS Medicinal Chemistry Letters Referencing Guide · ACS Medicinal Chemistry Letters citation (updated Mar 24 2023) · Citationsy
ACS Medicinal Chemistry Letters | Ahead of Print
ACS Med Chem Lett on Twitter: "Our new issue is out with cover art depicting the mechanism of action of vorasidenib (AG-881), a dual inhibitor of mutant IDH1 and 2 for the
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
September Publications | College of Pharmacy - University of Minnesota
Portfolio of hits — Laboratory of Medicinal Chemistry — Ghent University
![PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43610754/mini_magick20190215-24458-m15ml6.png?1550286693 "PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu")
PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu
Portfolio of hits — Laboratory of Medicinal Chemistry — Ghent University
Bioorganic & Medicinal Chemistry Letters template - For Authors
Bioorganic and Medicinal Chemistry Letters | EVISA's Journals Database
![8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.5b01635/asset/images/acs.jmedchem.5b01635.social.jpeg_v03 "8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors | Journal of Medicinal Chemistry")
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors | Journal of Medicinal Chemistry
ACS Medicinal Chemistry Letters impact factor and... | Exaly
Publications – Santos Lab
